Cefapirinum [INN-Latin] en es it fr

Cefapirinum [INN-Latin] Brand names, Cefapirinum [INN-Latin] Analogs

Cefapirinum [INN-Latin] Brand Names Mixture

  • Isotamine B 300 (Isoniazid + Pyridoxine Hydrochloride)
  • Rifater (Isoniazid + Pyrazinamide + Rifampin)

Cefapirinum [INN-Latin] Chemical_Formula


Cefapirinum [INN-Latin] RX_link

No information avaliable

Cefapirinum [INN-Latin] fda sheet

Cefapirinum [INN-Latin] msds (material safety sheet)

Cefapirinum_[INN-Latin] MSDS

Cefapirinum [INN-Latin] Synthesis Reference

No information avaliable

Cefapirinum [INN-Latin] Molecular Weight

423.466 g/mol

Cefapirinum [INN-Latin] Melting Point

No information avaliable

Cefapirinum [INN-Latin] H2O Solubility

1030 mg/L

Cefapirinum [INN-Latin] State


Cefapirinum [INN-Latin] LogP


Cefapirinum [INN-Latin] Dosage Forms

Gel; Suspension

Cefapirinum [INN-Latin] Indication

For treatment of infections caused by susceptible bacteria.

Cefapirinum [INN-Latin] Pharmacology

Cephapirin is a first-generation cephalosporin that has a wide spectrum of activity against gram-positive and gram-negative organisms. Cephapirin is more resistant to beta-lactamases than are the penicillins and so is effective against staphylococci, with the exception of methicillin-resistant staphylococci.

Cefapirinum [INN-Latin] Absorption

No information avaliable

Cefapirinum [INN-Latin] side effects and Toxicity

Rats exposed via the oral route to cephapirin displayed low acute toxicity (LD50 = 14000 mg/kg). The most common adverse reactions are hypersensitivity reactions and alterations to liver function. Evidence of white blood cell disorders and anaemia were noted in some subjects.

Cefapirinum [INN-Latin] Patient Information

No information avaliable

Cefapirinum [INN-Latin] Organisms Affected

Enteric bacteria and other eubacteria